These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32787764)

  • 21. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
    Yan P; Hu X; Song H; Yin K; Bateman RJ; Cirrito JR; Xiao Q; Hsu FF; Turk JW; Xu J; Hsu CY; Holtzman DM; Lee JM
    J Biol Chem; 2006 Aug; 281(34):24566-74. PubMed ID: 16787929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of matrix metalloproteinases and their inhibitors in the internal carotid artery wall in pathological tortuosity].
    Paltseva EM; Polyakova VO; Oskolkova SA; Abramyan AV; Ivanova AG; Krylova YS; Gavrilenko AV
    Arkh Patol; 2016; 78(3):26-31. PubMed ID: 27296003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
    Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
    Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells.
    Du H; Li P; Wang J; Qing X; Li W
    Cell Mol Neurobiol; 2012 Jan; 32(1):141-7. PubMed ID: 21837459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2.
    Fujimura M; Watanabe M; Shimizu H; Tominaga T
    Acta Neurochir (Wien); 2007 Feb; 149(2):179-83; discussion 183. PubMed ID: 17043747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
    Nalbandian A; Djakiew D
    Clin Exp Metastasis; 2006; 23(2):107-16. PubMed ID: 16912916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
    Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
    Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1.
    Vandooren J; Swinnen W; Ugarte-Berzal E; Boon L; Dorst D; Martens E; Opdenakker G
    Haematologica; 2017 Oct; 102(10):1671-1682. PubMed ID: 28775117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia.
    Reuter B; Rodemer C; Grudzenski S; Couraud PO; Weksler B; Romero IA; Meairs S; Bugert P; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2013; 35(6):514-20. PubMed ID: 23817219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
    Robinson LL; Sznajder NA; Riley SC; Anderson RA
    Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in low malignant potential ovarian tumors.
    Määttä M; Santala M; Soini Y; Talvensaari-Mattila A; Turpeenniemi-Hujanen T
    Tumour Biol; 2004; 25(4):188-92. PubMed ID: 15557756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
    Brehmer B; Biesterfeld S; Jakse G
    Prostate Cancer Prostatic Dis; 2003; 6(3):217-22. PubMed ID: 12970724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
    Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
    J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model.
    Zara S; Rapino M; Sozio P; Di Stefano A; Nasuti C; Cataldi A
    Brain Res; 2011 Sep; 1412():79-87. PubMed ID: 21820649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro secretion and activity profiles of matrix metalloproteinases, MMP-9 and MMP-2, in human term extra-placental membranes after exposure to Escherichia coli.
    Zaga-Clavellina V; Garcia-Lopez G; Flores-Pliego A; Merchant-Larios H; Vadillo-Ortega F
    Reprod Biol Endocrinol; 2011 Jan; 9():13. PubMed ID: 21266053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
    Bernardo MM; Fridman R
    Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinases -2 and -9 and their endogenous tissue inhibitors in fetal membrane repair following fetoscopy in a rabbit model.
    Devlieger R; Deprest JA; Gratacós E; Pijnenborg R; Leask R; Riley SC
    Mol Hum Reprod; 2000 May; 6(5):479-85. PubMed ID: 10775654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease.
    Lim NK; Villemagne VL; Soon CP; Laughton KM; Rowe CC; McLean CA; Masters CL; Evin G; Li QX
    J Alzheimers Dis; 2011; 26(4):779-86. PubMed ID: 21694463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.